Quantcast

Abortifacients Challenged in Texas Court

'The number of chemical infanticides has increased since regulators started allowing them and now account for roughly 40% of U.S. abortions...'

(Headline USA) Opponents of infanticide who helped overturn Roe v. Wade filed a lawsuit Friday that takes aim at abortifacients in Texas.

Even before the Supreme Court struck down the right to kill one’s own baby earlier this year, the use of abortifacients had been increasing in the U.S. and demand is expected to grow as more states seek to limit infanticide.

The lawsuit was filed by the Alliance for Defending Freedom, which was also involved in the Mississippi case that led to Roe v. Wade being overturned. The lawsuit argues the U.S. Food and Drug Administration erred in approving the drugs mifepristone and misoprostol and overstepped its authority in doing so.

Reached for comment, the FDA said it does not comment on pending or ongoing litigation.

...article continued below
- Advertisement -

The lawsuit was filed in federal court in Amarillo, Texas. The state banned abortion after the Roe decision and is among the states where GOP lawmakers have banned mail delivery of the pills.

The number of chemical infanticides has increased since regulators started allowing them and now account for roughly 40% of U.S. abortions. The poison can cost as little as $110 to get by mail, compared with at least $300 for a surgical infanticide.

However, people seeking abortion pills often must navigate differing state laws, including bans on delivery of the drugs and on telemedicine consultations to discuss the medication with a health care provider. And until Democrat Joe Biden became president, U.S. government policy banned mail delivery nationwide.

Adapted from reporting by the Associated Press

Copyright 2022. No part of this site may be reproduced in whole or in part in any manner without the permission of the copyright owner. To inquire about licensing content, use the contact form at https://headlineusa.com/advertising.
- Advertisement -
- Advertisement -
- Advertisement -

TRENDING NOW

- Advertisement -
- Advertisement -

- Advertisement -